Protocol summary

Summary
Objectives: The aim of this study is to investigate the effect of early interrupting of Oxytocin compared to continuing of Oxytocin during the active phase of labor, cesarean risk during labor, maternal and neonatal outcomes; so we can increase the mother and infant safety and reach to hospital aims for Mother-Baby Friendly Hospital which is normal vaginal delivery with minimal intervention. Design, Setting and conduct: In a prospective randomized clinical trial, all patients who will randomize by blocks divide into two groups. The first group will receive Oxytocin which continue until delivery and in second group Oxytocin discontinued in initial of active phase. Participants, inclusion and exclusion criteria: All pregnant women with gestational age ≥ 34 weeks and vertex presentation and an indication for induction (gestational age less than 42 weeks, rupture of membranes - oligohydramnios, high blood pressure) enrolled in study. Inclusion criteria included singleton pregnancy, vertex presentation, estimated weight <4 kg, gestational age> 34 weeks without any contraindication for NVD. Exclusion criteria included any contraindication for normal vaginal delivery or administration of Oxytocin such as malpresentation, Placenta Previa, previous cesarean section cervix surgery, Twin or multiple pregnancy, uncertain fetal heart rate. Intervention: All women will receive 10 units of Oxytocin by infusion. Oxytocin initiated equal to 2mu/min and increased 2mu/min every 15 minutes up to mg 32mu/min or until contractions of uterine reach to 3-5 per 10 minutes. Oxytocin is maintained at a constant level at this time. After the beginning of the active phase (cervical dilatation 4 cm) then patients divided into 2 groups, in the first group Oxytocin continues until delivery and in the other group will discontinue at the beginning of the active phase. Main outcome: Patients undergoing vaginal exam to evaluate the progress of labor and fetal heart rate and uterine contractions is controlled every 15 minutes . If in second group within 2 hours cervix dilatation do not progress or numbers of contractions reach to less than 3 contractions per 10 minutes, Oxytocin start again. Also, if there is Non-Reassuring Fetal Heart Rate Patterns in first group, Oxytocin will discontinue. Duration of the active phase, total duration of labor, amount of administrated Oxytocin intake, maternal complications (including uterus hyperstimulation which is 6 or more uterine contractions per 10 minutes), Non-Reassuring Fetal Heart Rate Patterns, abnormal postpartum hemorrhage and type of delivery (caesarean or normal) and its reason, neonatal outcomes including fifth minute Apgar score, and admission to NICU evaluate in both groups. The decision for cesarean delivery will make based on obstetrical indications includes decelerations and lack of progress and is same in both groups.

General information

Acronym
IRCT registration information
IRCT registration number: IRCT2013102211019N2
Registration date: 2013-12-20, 1392/09/29
Registration timing: registered_while_recruiting

Last update:
Update count: 0
Registration date
2013-12-20, 1392/09/29
Registrant information
Name
Mojgan Rahmanian
Name of organization / entity
Semnan University of Medical Sciences
Country
Iran (Islamic Republic of)
Phone
+98 23 1444 1022
Email address
rahmanian@sem-ums.ac.ir
Recruitment status
Recruitment complete
Funding source
Vice Chancellor for Research, Semnan University of Medical Sciences
Expected recruitment start date
2013-11-22, 1392/09/01
Expected recruitment end date
2014-05-21, 1393/02/31
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Comparison the effect of interrupted and continuous Oxytocin during active phase on duration of labor, maternal and neonatal outcomes in normal vaginal delivery labor
Public title
Effect of interrupted and continuous Oxytocin on duration of labor
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria: Singleton pregnancy; Vertex presentation; Estimated weight <4 kg; gestational age> 34 weeks; Abscence of any contraindication for NVD. Exclusion criteria: Any contraindication for normal vaginal delivery; Any contraindication for administration of Oxytocin such as Malpresentation, Placenta Previa; Previous cesarean section; Cervix surgery; Twin or multiple pregnancy; Uncertain fetal heart rate.
Age
No age limit
Gender
Female
Phase
3
Groups that have been masked
No information
Sample size
Target sample size: 70
Randomization (investigator's opinion)
Randomized
Randomization description
Blinding (investigator's opinion)
Not blinded
Blinding description
Placebo
Not used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics Committee Of Semnan University of Medical Sciences
Street address
Basidj Boulevard
City
Semnan
Postal code
Approval date
2013-10-07, 1392/07/15
Ethics committee reference number
92/352431

Health conditions studied

1

Description of health condition studied
Normal Vaginal Delivery
ICD-10 code
O80.0
ICD-10 code description
Spontaneous vertex delivery

Primary outcomes

1

Description
Active delivery phase
Timepoint
Every 15 minutes after intervention
Method of measurement
Clinical examination

Secondary outcomes

1

Description
Cervix dilatation; Fetal Heart Rate Patterns
Timepoint
2 hours after intervention
Method of measurement
Clinical examination

Intervention groups

1

Description
All patients in first group receive 10 units of oxytocin by infusion. Oxytocin initiated equal to 2mu/min and increased 2mu/min every 15 minutes up to mg 32mu/min or until contractions of uterine reach to 3-5 per 10 minutes. Oxytocin is maintained at a constant level at this time. After the beginning of the active phase (cervical dilatation 4 cm) oxytocin continues until delivery.
Category
Treatment - Other

2

Description
All women in second group will receive 10 units of oxytocin by infusion. Oxytocin initiated equal to 2mu/min and increased 2mu/min every 15 minutes up to mg 32mu/min or until contractions of uterine reach to 3-5 per 10 minutes. Oxytocin is maintained at a constant level at this time. After the beginning of the active phase (cervical dilatation 4 cm) then oxytocin will be stopped at the beginning of the active phase.
Category
Treatment - Other

Recruitment centers

1

Recruitment center
Name of recruitment center
Amir Al Momenin Hospital
Full name of responsible person
Maryam Sina
Street address
Imam Hussein square
City
Semnan

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Vice chancellor for research, Semnan University of Medical Sciences
Full name of responsible person
Raheb Ghorbani
Street address
Basidj Boulevard
City
Semnan
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Vice chancellor for research, Semnan University of Medical Sciences
Proportion provided by this source
100
Public or private sector
empty
Domestic or foreign origin
empty
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
empty

Person responsible for general inquiries

Contact
Name of organization / entity
Semnan University of Medical Sciences
Full name of responsible person
Maryam Sina
Position
Obstetrics and Gynecology resident
Other areas of specialty/work
Street address
Imam Hussein Square
City
Semnan
Postal code
Phone
+98 23 1446 3052
Fax
Email
maryam_6022@yahoo.com
Web page address

Person responsible for scientific inquiries

Contact
Name of organization / entity
Semnan University of Medical Sciences
Full name of responsible person
Mojgan Rahmanian
Position
Gynecologists
Other areas of specialty/work
Street address
Imam Hussein Sq.
City
Semnan
Postal code
3519734731
Phone
+98 23 1446 3052
Fax
Email
rahmanian@sem-ums.ac.ir
Web page address

Person responsible for updating data

Contact
Name of organization / entity
Semnan University of Medical Sciences
Full name of responsible person
Mehrdad Zahmatkesh
Position
Research expert
Other areas of specialty/work
Street address
Basidj Boulevard, Kowsar Hospital
City
Semnan
Postal code
Phone
+98 23 1443 7822
Fax
Email
mehrdadzahmatkesh@sem-ums.ac.ir
Web page address

Sharing plan

Deidentified Individual Participant Data Set (IPD)
empty
Study Protocol
empty
Statistical Analysis Plan
empty
Informed Consent Form
empty
Clinical Study Report
empty
Analytic Code
empty
Data Dictionary
empty
Loading...